CYDY Final Deadline Notice: Rosen, A Leading Law Firm, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - CYDYNewsfile Corp • 05/15/21
CYDY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 17, 2021 in the Class Action Filed on Behalf of CytoDyn Inc. Limited ShareholdersNewsfile Corp • 05/14/21
CYDY FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - CYDYNewsfile Corp • 05/14/21
CYDY LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving CytoDyn Inc.Newsfile Corp • 05/14/21
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNewsfile Corp • 05/14/21
Last Day For Shareholders With Losses Exceeding $400K to Actively Participate in CytoDyn, Inc. (CYDY) Class Action and Lead Plaintiff Deadline: May 17, 2021 - Bronstein, Gewirtz & Grossman, LLCBusiness Wire • 05/14/21
CYTODYN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CytoDyn, Inc. - CYDYNewsfile Corp • 05/14/21
Final Deadline Approaching on May 17, 2021: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Class Action Lawsuit DeadlinePRNewsWire • 05/13/21
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)Business Wire • 05/13/21
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNewsfile Corp • 05/13/21
CytoDyn strikes supply and distribution deal with Indian firm for leronlimb as coronavirus treatmentProactive Investors • 05/13/21
CytoDyn Signs Distribution Agreement with Macleods Pharmaceuticals Ltd. to Pursue EUA and Compassionate Use Access to Leronlimab in IndiaGlobeNewsWire • 05/13/21
Rosen, A Top Ranked Law Firm, Encourages CytoDyn Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDYNewsfile Corp • 05/12/21
Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against CytoDyn Inc. (CYDY)Business Wire • 05/12/21
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNewsfile Corp • 05/12/21
CYDY ALERT: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 05/11/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.Newsfile Corp • 05/10/21
CYDY Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against CytoDyn Inc.Newsfile Corp • 05/07/21
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDYPRNewsWire • 05/06/21
CytoDyn strikes agreement with AEIH in Brazil to run two coronavirus trials using its flagship drug leronlimabProactive Investors • 05/05/21
CytoDyn Reaches Agreement with Albert Einstein Israelite Hospital in Brazil to Conduct Two COVID-19 Trials - a Small Trial in Critically Ill and a Large Trial in Severe PopulationsGlobeNewsWire • 05/05/21
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of CytoDyn Inc. of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 05/04/21
Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. (CYDY)PRNewsWire • 05/03/21